Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Acute Kidney Injury | Research

Knockdown of circ-Gatad1 alleviates LPS induced HK2 cell injury via targeting miR-22-3p/TRPM7 axis in septic acute kidney

Authors: Pan Zhang, Enwei Guo, Limin Xu, Zhenhua Shen, Na Jiang, Xinghui Liu

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Sepsis is a life-threatening, systemic inflammatory disease that can lead to a variety of conditions, including septic acute kidney injury (AKI). Recently, multiple circular Rnas (circRNAs) have been implicated in the development of this disease.

Methods

In this study, we aimed to elucidate the role of circ-Gatad1 in sepsis induced AKI and its potential mechanism of action. High-throughput sequencing was used to investigate abnormal expression of circRNA in AKI and healthy volunteer. Bioinformatics analysis and luciferase reporting analysis were used to clarify the interacted relationship among circRNA, miRNA and mRNA. HK2 cells were treated with lipopolysaccharide (LPS) to establish septic AKI cell model. HK2 cells were employ to analysis the ROS, inflammatory cytokines expression, proliferation and apoptosis under LPS condition.

Results

The result show that the expression of circ-Gatad1 was increased in septic acute kidney patients. Downregulation circ-Gatad1 suppressed LPS-treated induced HK2 cells injury including apoptosis, proliferation ability, ROS and inflammatory cytokines level. Bioinformatics and luciferase report analysis confirmed that both miR-22-3p and TRPM7 were downstream targets of circ-Gatad1. Overexpression of TRPM7 or downregulation of miR-22-3p reversed the protective effect of si-circ-Gatad1 to HK2 after exposure to LPS (5 µg/ml) microenvironment.

Conclusion

In conclusion, knockdown of circ-Gatad1 alleviates LPS induced HK2 cell injury via targeting miR-22-3p/TRPM7 axis in septic acute kidney.
Literature
1.
go back to reference Ge C, Peng Q, Chen W, Li W, Zhang L, Ai Y. Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock. Sci Rep. 2021;11:24083.CrossRefPubMedPubMedCentral Ge C, Peng Q, Chen W, Li W, Zhang L, Ai Y. Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock. Sci Rep. 2021;11:24083.CrossRefPubMedPubMedCentral
2.
go back to reference Miyamoto Y, Iwagami M, Aso S, Yasunaga H, Matsui H, Fushimi K, et al. Temporal change in characteristics and outcomes of acute kidney injury on renal replacement therapy in intensive care units: analysis of a nationwide administrative database in Japan, 2007–2016. Crit Care. 2019;23:172.CrossRefPubMedPubMedCentral Miyamoto Y, Iwagami M, Aso S, Yasunaga H, Matsui H, Fushimi K, et al. Temporal change in characteristics and outcomes of acute kidney injury on renal replacement therapy in intensive care units: analysis of a nationwide administrative database in Japan, 2007–2016. Crit Care. 2019;23:172.CrossRefPubMedPubMedCentral
4.
go back to reference Netti GS, Sangregorio F, Spadaccino F, Staffieri F, Crovace A, Infante B, et al. LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis. Am J Physiol Ren Physiol. 2019;316:F723–f731.CrossRef Netti GS, Sangregorio F, Spadaccino F, Staffieri F, Crovace A, Infante B, et al. LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis. Am J Physiol Ren Physiol. 2019;316:F723–f731.CrossRef
5.
go back to reference Stoyanoff TR, Todaro JS, Aguirre MV, Zimmermann MC, Brandan NC. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis. Toxicology. 2014;318:13–21.CrossRefPubMed Stoyanoff TR, Todaro JS, Aguirre MV, Zimmermann MC, Brandan NC. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis. Toxicology. 2014;318:13–21.CrossRefPubMed
6.
go back to reference Moreira RS, Irigoyen M, Sanches TR, Volpini RA, Camara NO, Malheiros DM, et al. Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis. Am J Physiol Regul Integr Comp Physiol. 2014;307:R514–524.CrossRefPubMed Moreira RS, Irigoyen M, Sanches TR, Volpini RA, Camara NO, Malheiros DM, et al. Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis. Am J Physiol Regul Integr Comp Physiol. 2014;307:R514–524.CrossRefPubMed
7.
go back to reference Huang G, Bao J, Shao X, Zhou W, Wu B, Ni Z, et al. Inhibiting pannexin-1 alleviates sepsis-induced acute kidney injury via decreasing NLRP3 inflammasome activation and cell apoptosis. Life Sci. 2020;254:117791.CrossRefPubMed Huang G, Bao J, Shao X, Zhou W, Wu B, Ni Z, et al. Inhibiting pannexin-1 alleviates sepsis-induced acute kidney injury via decreasing NLRP3 inflammasome activation and cell apoptosis. Life Sci. 2020;254:117791.CrossRefPubMed
8.
go back to reference Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2021;12:911–46.CrossRefPubMed Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell. 2021;12:911–46.CrossRefPubMed
9.
10.
go back to reference Bao X, Zhang Q, Liu N, Zhuang S, Li Z, Meng Q, et al. Characteristics of circular RNA expression of pulmonary macrophages in mice with sepsis-induced acute lung injury. J Cell Mol Med. 2019;23:7111–5.CrossRefPubMedPubMedCentral Bao X, Zhang Q, Liu N, Zhuang S, Li Z, Meng Q, et al. Characteristics of circular RNA expression of pulmonary macrophages in mice with sepsis-induced acute lung injury. J Cell Mol Med. 2019;23:7111–5.CrossRefPubMedPubMedCentral
11.
go back to reference Li H, Zhang X, Wang P, Zhou X, Liang H, Li C. Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93-5p/OXSR1 axis in septic acute kidney injury. Diabetol Metab Syndr. 2021;13:7.CrossRefPubMedPubMedCentral Li H, Zhang X, Wang P, Zhou X, Liang H, Li C. Knockdown of circ-FANCA alleviates LPS-induced HK2 cell injury via targeting miR-93-5p/OXSR1 axis in septic acute kidney injury. Diabetol Metab Syndr. 2021;13:7.CrossRefPubMedPubMedCentral
12.
go back to reference Huang Y, Zheng G. Circ_UBE2D2 attenuates the progression of septic acute kidney Injury in rats by targeting miR-370-3p/NR4A3 Axis. J Microbiol Biotechnol. 2022;32:740–8.CrossRefPubMedPubMedCentral Huang Y, Zheng G. Circ_UBE2D2 attenuates the progression of septic acute kidney Injury in rats by targeting miR-370-3p/NR4A3 Axis. J Microbiol Biotechnol. 2022;32:740–8.CrossRefPubMedPubMedCentral
13.
go back to reference Cao J, Shi D, Zhu L, Song L. Circ_RASGEF1B promotes LPS-Induced apoptosis and inflammatory response by targeting MicroRNA-146a-5p/Pdk1 Axis in Septic Acute kidney Injury Cell Model. Nephron. 2021;145:748–59.CrossRefPubMed Cao J, Shi D, Zhu L, Song L. Circ_RASGEF1B promotes LPS-Induced apoptosis and inflammatory response by targeting MicroRNA-146a-5p/Pdk1 Axis in Septic Acute kidney Injury Cell Model. Nephron. 2021;145:748–59.CrossRefPubMed
15.
go back to reference Cruz MG, Dantas JG, Levi TM, Rocha Mde S, de Souza SP, Boa-Sorte N, et al. Septic versus non-septic acute kidney injury in critically ill patients: characteristics and clinical outcomes. Rev Bras Ter Intensiva. 2014;26:384–91.CrossRefPubMedPubMedCentral Cruz MG, Dantas JG, Levi TM, Rocha Mde S, de Souza SP, Boa-Sorte N, et al. Septic versus non-septic acute kidney injury in critically ill patients: characteristics and clinical outcomes. Rev Bras Ter Intensiva. 2014;26:384–91.CrossRefPubMedPubMedCentral
16.
go back to reference Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, et al. Sepsis as a cause and consequence of acute kidney injury: program to Improve Care in Acute Renal Disease. Intensive Care Med. 2011;37:241–8.CrossRefPubMed Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, et al. Sepsis as a cause and consequence of acute kidney injury: program to Improve Care in Acute Renal Disease. Intensive Care Med. 2011;37:241–8.CrossRefPubMed
17.
go back to reference Tan C, Gu J, Li T, Chen H, Liu K, Liu M et al. Inhibition of aerobic glycolysis alleviates sepsis–induced acute kidney injury by promoting lactate/Sirtuin 3/AMPK–regulated autophagy. Int J Mol Med. 2021;47. Tan C, Gu J, Li T, Chen H, Liu K, Liu M et al. Inhibition of aerobic glycolysis alleviates sepsis–induced acute kidney injury by promoting lactate/Sirtuin 3/AMPK–regulated autophagy. Int J Mol Med. 2021;47.
19.
go back to reference Ouyang X, He Z, Fang H, Zhang H, Yin Q, Hu L, et al. A protein encoded by circular ZNF609 RNA induces acute kidney injury by activating the AKT/mTOR-autophagy pathway. Mol Ther. 2023;31:1722–38.CrossRefPubMed Ouyang X, He Z, Fang H, Zhang H, Yin Q, Hu L, et al. A protein encoded by circular ZNF609 RNA induces acute kidney injury by activating the AKT/mTOR-autophagy pathway. Mol Ther. 2023;31:1722–38.CrossRefPubMed
20.
go back to reference Shum HP, Yan WW, Chan TM. Recent knowledge on the pathophysiology of septic acute kidney injury: a narrative review. J Crit Care. 2016;31:82–9.CrossRefPubMed Shum HP, Yan WW, Chan TM. Recent knowledge on the pathophysiology of septic acute kidney injury: a narrative review. J Crit Care. 2016;31:82–9.CrossRefPubMed
21.
go back to reference Jacobs R, Honore PM, Joannes-Boyau O, Boer W, De Regt J, De Waele E, et al. Septic acute kidney injury: the culprit is inflammatory apoptosis rather than ischemic necrosis. Blood Purif. 2011;32:262–5.CrossRefPubMed Jacobs R, Honore PM, Joannes-Boyau O, Boer W, De Regt J, De Waele E, et al. Septic acute kidney injury: the culprit is inflammatory apoptosis rather than ischemic necrosis. Blood Purif. 2011;32:262–5.CrossRefPubMed
22.
go back to reference Koçkara A, Kayataş M. Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury. Ren Fail. 2013;35:291–4.CrossRefPubMed Koçkara A, Kayataş M. Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury. Ren Fail. 2013;35:291–4.CrossRefPubMed
23.
go back to reference Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care. 2003;9:496–502.CrossRefPubMed Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care. 2003;9:496–502.CrossRefPubMed
24.
go back to reference Wang S, Zeng M, Li B, Kan Y, Zhang B, Zheng X, et al. Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway. Biomed Pharmacother. 2020;129:110403.CrossRefPubMed Wang S, Zeng M, Li B, Kan Y, Zhang B, Zheng X, et al. Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway. Biomed Pharmacother. 2020;129:110403.CrossRefPubMed
25.
go back to reference Wang X, Wang Y, Kong M, Yang J. MiR-22-3p suppresses sepsis-induced acute kidney injury by targeting PTEN. Biosci Rep. 2020;40. Wang X, Wang Y, Kong M, Yang J. MiR-22-3p suppresses sepsis-induced acute kidney injury by targeting PTEN. Biosci Rep. 2020;40.
26.
go back to reference Zhang J, Chen Q, Dai Z, Pan H. miR-22 alleviates sepsis-induced acute kidney injury via targeting the HMGB1/TLR4/NF-κB signaling pathway. Int Urol Nephrol. 2023;55:409–21.CrossRefPubMed Zhang J, Chen Q, Dai Z, Pan H. miR-22 alleviates sepsis-induced acute kidney injury via targeting the HMGB1/TLR4/NF-κB signaling pathway. Int Urol Nephrol. 2023;55:409–21.CrossRefPubMed
27.
go back to reference Zhang H, Che L, Wang Y, Zhou H, Gong H, Man X, et al. Deregulated microRNA-22-3p in patients with sepsis-induced acute kidney injury serves as a new biomarker to predict disease occurrence and 28-day survival outcomes. Int Urol Nephrol. 2021;53:2107–16.CrossRefPubMed Zhang H, Che L, Wang Y, Zhou H, Gong H, Man X, et al. Deregulated microRNA-22-3p in patients with sepsis-induced acute kidney injury serves as a new biomarker to predict disease occurrence and 28-day survival outcomes. Int Urol Nephrol. 2021;53:2107–16.CrossRefPubMed
28.
go back to reference Sun Y, Chen X, Xie Y, Wang Y, Zhang Q, Lu Y, et al. TRPM7 promotes lipopolysaccharide-induced inflammatory dysfunction in renal tubular epithelial cells. Immun Inflamm Dis. 2022;10:e641.CrossRefPubMedPubMedCentral Sun Y, Chen X, Xie Y, Wang Y, Zhang Q, Lu Y, et al. TRPM7 promotes lipopolysaccharide-induced inflammatory dysfunction in renal tubular epithelial cells. Immun Inflamm Dis. 2022;10:e641.CrossRefPubMedPubMedCentral
29.
go back to reference Liu A, Yang B. Roles of TRPM7 in Renal Ischemia-Reperfusion Injury. Curr Protein Pept Sci. 2019;20:777–88.CrossRefPubMed Liu A, Yang B. Roles of TRPM7 in Renal Ischemia-Reperfusion Injury. Curr Protein Pept Sci. 2019;20:777–88.CrossRefPubMed
Metadata
Title
Knockdown of circ-Gatad1 alleviates LPS induced HK2 cell injury via targeting miR-22-3p/TRPM7 axis in septic acute kidney
Authors
Pan Zhang
Enwei Guo
Limin Xu
Zhenhua Shen
Na Jiang
Xinghui Liu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03513-1

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.